Chargement en cours...
Fueling chimeric antigen receptor T cells with cytokines
Chimeric antigen receptor (CAR)-T therapy started a new era of tumor treatment, especially for hematological malignancies. However, many challenges remain, including low-level proliferation and short-term persistence, insufficient CAR T-cell trafficking, suppressive tumor microenvironment (TME), fre...
Enregistré dans:
| Publié dans: | Am J Cancer Res |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
e-Century Publishing Corporation
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7783740/ https://ncbi.nlm.nih.gov/pubmed/33414984 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|